Your browser doesn't support javascript.
loading
Synthetic methods of lipid-coated mesoporous silica nanoparticles as drug carriers.
Sun, Yanping; Xu, Youqiang; Sun, Yongjun; Hu, Beibei; Wang, Long; Du, Zhidian; Gao, Zibin.
Afiliação
  • Sun Y; Department of Pharmacy, Hebei University of Science and Technology, Shijiazhuang 050018, China.
  • Xu Y; Department of Pharmacy, Hebei University of Science and Technology, Shijiazhuang 050018, China.
  • Sun Y; Department of Pharmacy, Hebei University of Science and Technology, Shijiazhuang 050018, China.
  • Hu B; Department of Pharmacy, Hebei University of Science and Technology, Shijiazhuang 050018, China.
  • Wang L; School of Health Sciences, University of the Pacific, Sacramento, California 95817.
  • Du Z; Department of Pharmacy, Hebei University of Science and Technology, Shijiazhuang 050018, China.
  • Gao Z; Department of Pharmacy, Hebei University of Science and Technology, Shijiazhuang 050018, China.
Biointerphases ; 17(2): 020801, 2022 03 01.
Article em En | MEDLINE | ID: mdl-35232023
ABSTRACT
The lipid-coated mesoporous silica nanoparticles (LMSNs) that can synergistically harness the advantages and mitigate the disadvantages of the liposomes and MSNs are considered potential drug carriers. So far, several methods have been developed to prepare LMSNs, including vesicle fusion, thin-film hydration, and solvent exchange. Despite their wide application in LMSN preparation, these methods are short of detailed elaboration and comparison, which hinders their further development. In this review, for the first time, the three methods are systematically summarized, including their mechanisms, influence factors, advantages, and limitations. Although these methods are all based on lipid self-assembly, there is still a difference between them. In order to efficiently prepare LMSNs, we proposed that a suitable method should be selected based on the actual situation. It is conceivable that the elaboration and comparison in this review will make these methods easy to be understood and provide guidance for the design of LMSNs as drug carriers.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dióxido de Silício / Nanopartículas Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dióxido de Silício / Nanopartículas Idioma: En Ano de publicação: 2022 Tipo de documento: Article